1. Home
  2. TNXP vs FRBA Comparison

TNXP vs FRBA Comparison

Compare TNXP & FRBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • FRBA
  • Stock Information
  • Founded
  • TNXP 2007
  • FRBA 2007
  • Country
  • TNXP United States
  • FRBA United States
  • Employees
  • TNXP N/A
  • FRBA N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • FRBA Major Banks
  • Sector
  • TNXP Health Care
  • FRBA Finance
  • Exchange
  • TNXP Nasdaq
  • FRBA Nasdaq
  • Market Cap
  • TNXP 335.6M
  • FRBA 364.6M
  • IPO Year
  • TNXP N/A
  • FRBA N/A
  • Fundamental
  • Price
  • TNXP $51.35
  • FRBA $15.75
  • Analyst Decision
  • TNXP Buy
  • FRBA Strong Buy
  • Analyst Count
  • TNXP 1
  • FRBA 2
  • Target Price
  • TNXP $70.00
  • FRBA $18.00
  • AVG Volume (30 Days)
  • TNXP 1.8M
  • FRBA 49.4K
  • Earning Date
  • TNXP 08-11-2025
  • FRBA 07-22-2025
  • Dividend Yield
  • TNXP N/A
  • FRBA 1.52%
  • EPS Growth
  • TNXP N/A
  • FRBA 22.16
  • EPS
  • TNXP N/A
  • FRBA 1.51
  • Revenue
  • TNXP $9,831,000.00
  • FRBA $131,202,000.00
  • Revenue This Year
  • TNXP $22.87
  • FRBA $10.99
  • Revenue Next Year
  • TNXP $711.66
  • FRBA $6.16
  • P/E Ratio
  • TNXP N/A
  • FRBA $10.43
  • Revenue Growth
  • TNXP N/A
  • FRBA 14.51
  • 52 Week Low
  • TNXP $6.76
  • FRBA $12.74
  • 52 Week High
  • TNXP $130.00
  • FRBA $16.47
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 55.76
  • FRBA 57.55
  • Support Level
  • TNXP $42.12
  • FRBA $15.58
  • Resistance Level
  • TNXP $69.97
  • FRBA $16.12
  • Average True Range (ATR)
  • TNXP 6.06
  • FRBA 0.35
  • MACD
  • TNXP 1.01
  • FRBA 0.10
  • Stochastic Oscillator
  • TNXP 45.73
  • FRBA 78.24

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About FRBA First Bank

First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.

Share on Social Networks: